Head to Head Comparison: First Choice Healthcare Solutions (OTCMKTS:FCHS) & Avantor (NYSE:AVTR)

First Choice Healthcare Solutions (OTCMKTS:FCHS) and Avantor (NYSE:AVTR) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, risk, valuation and profitability.

Earnings and Valuation

This table compares First Choice Healthcare Solutions and Avantor”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
First Choice Healthcare Solutions	$10,000.00	12.20	-$6.96 million	($0.20)	-0.02
Avantor	$6.55 billion	0.82	-$530.20 million	($0.78)	-10.12

First Choice Healthcare Solutions has higher earnings, but lower revenue than Avantor. Avantor is trading at a lower price-to-earnings ratio than First Choice Healthcare Solutions, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares First Choice Healthcare Solutions and Avantor’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
First Choice Healthcare Solutions	N/A	N/A	-165.98%
Avantor	-8.09%	10.45%	5.06%

Analyst Recommendations

This is a summary of recent recommendations and price targets for First Choice Healthcare Solutions and Avantor, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
First Choice Healthcare Solutions	0	0	0	0	0.00
Avantor	3	10	3	0	2.00

Avantor has a consensus price target of $11.80, suggesting a potential upside of 49.52%. Given Avantor’s stronger consensus rating and higher probable upside, analysts plainly believe Avantor is more favorable than First Choice Healthcare Solutions.

Insider and Institutional Ownership

95.1% of Avantor shares are owned by institutional investors. 30.8% of First Choice Healthcare Solutions shares are owned by company insiders. Comparatively, 1.2% of Avantor shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility & Risk

First Choice Healthcare Solutions has a beta of 0.33, indicating that its share price is 67% less volatile than the S&P 500. Comparatively, Avantor has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.

Summary

Avantor beats First Choice Healthcare Solutions on 8 of the 14 factors compared between the two stocks.

About First Choice Healthcare Solutions

First Choice Healthcare Solutions, Inc. provides healthcare services in the United States. It develops primary care and wellness clinics focused on providing life improvement services, such as anti-aging, weight management, hormone replacement, and pharmacy services. The company is headquartered in Melbourne, Florida.

About Avantor

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.